InvestorsHub Logo
Followers 7
Posts 6049
Boards Moderated 0
Alias Born 06/27/2018

Re: None

Tuesday, 01/23/2024 9:32:28 AM

Tuesday, January 23, 2024 9:32:28 AM

Post# of 13962
Super strange.

NAYA entered into a binding Term Sheet with Florida Biotechnologies Inc. to acquire all of the outstanding capital stock of Florida Biotechnologies for $20,000,000 in shares of NAYA post-merger with INVO, or 4,000,000 shares, each worth $5.00 (the "Florida Biotechnologies Transaction"). Florida Biotechnologies is eligible for an additional $5,000,000, or 1,000,000 shares each worth $5.00, upon achievement of certain milestones. The Florida Biotechnologies Transaction is contingent on the closing of the INVO Merger and sufficient financing to further develop the gene therapy programs from Florida Biotechnologies.
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.